pharma news today obesity drugs glp-1 september 2025 IQVIA Early Bird: Revealed - The Trends Shaping Pharma's Future Patent and Innovation Trends in
Description
GLP-1 medications are not generally considered controlled substances under the Ryan Haight Act, so standard controlled substance telehealth prescribing restrictions don't apply
And if you're new to Ozempic or Wegovy, your first two months of treatment will cost just $199 per month
Mounjaro (tirzepatide) Mounjaro activates both GLP1 and GIP receptors
What makes the difference
For people without insurance coverage, compounded semaglutide is often a financially accessible option
Very pricey for .5 dosage Fast delivery, great products Easy to use and instructions are very clear
